TMJ: N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE
TMJ is a Ligand Of Interest in 2ONZ designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 2ONZ_TMJ_B_2002 | 86% | 20% | 0.091 | 0.959 | 1.5 | 1.85 | 2 | 1 | 1 | 0 | 100% | 1 |
| 2ONZ_TMJ_A_2001 | 71% | 22% | 0.111 | 0.932 | 1.48 | 1.74 | 2 | 2 | 1 | 0 | 100% | 1 |
| 2ONY_TMJ_A_2001 | 29% | 22% | 0.194 | 0.851 | 1.52 | 1.73 | 2 | 2 | 0 | 0 | 100% | 1 |
